NPHCNutra Pharma Corp.
Price Chart
Loading chart...
About Nutra Pharma Corp. (NPHC)
Nutra Pharma Corp. (NPHC) is a Drug Manufacturers - Specialty & Generic company headquartered in Plantation, FL, United States whose shares trade over-the-counter on the Expert Market tier.
Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, including Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. Additionally, the Company markets drug products for sale for the treatment of pain under the brands Nyloxin, Pet Pain-Away, Equine Pain-Away and Luxury Feet..
Products and services
Nutra Pharma Corporation has ethical drugs in clinical development for the treatment of Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain. Our MS drug has received Orphan Designation from the FDA for the treatment of juvenile MS. Additionally, the Company markets drug products for sale for the treatment of pain under the brands Nyloxin®, Luxury Feet™, Equine Pain-Away™ and Pet Pain-Away™. The Company is also working on nerve agent countermeasures against organophosphate chemicals. Lastly, the company produces homeopathic drugs and dietary supplements for several private label customers, including Avini Health.
NPHC key facts
- Ticker symbol
- NPHC
- Market tier
- Expert Market
- Sector
- Healthcare
- Headquarters
- Plantation, FL, United States
- Country of incorporation
- US
- Year of incorporation
- 2000
- Employees
- 8
- Estimated market cap
- $2.13M (as of Apr 16, 2025)
- Shares outstanding
- 7,099,739,773
- Reporting standard
- U.S. Reporting: SEC Reporting
- Audit status
- Audited
- Fiscal year end
- 12/31
Nutra Pharma Corp. leadership
- Michael Flax — CEO
- Rik J Deitsch — Manager, Ops.
Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with N
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for Nutra Pharma Corp. (NPHC) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Drug Manufacturers - Specialty & Generic Companies on OTC Markets
Other OTC-traded companies in Drug Manufacturers - Specialty & Generic:
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Company Leadership
Chief Executive Officer
Company Officers
Social Media
Business Details
Stock Details
Loading modules...